FDA Inspection
Octapharma Plasma Inc.Octapharma Plasma Inc. – FDA Inspection, Jun 5, 2025
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc., with an inspection on June 5, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · bd0cdbbf-1911-4f27-a9fb-c01c9d8d5203
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1270455
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 630.10(a)Donor Eligibility Factors
- 21 CFR 606.100(b)(2)Donor qualifying tests & measurements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma Inc.
- FDA Inspection 1154399 - 2021-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.